Enzymatic oxidation of vanillin, isovanillin and protocatechuic aldehyde with freshly prepared guinea pig liver slices

Cellular Physiology and Biochemistry

Volumn 15, Issue 1-4, 2005, Pages 89-98

  Panoutsopoulos, Georgios I ^a,b,c   Beedham, Christine ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b UNIVERSITY OF THESSALY   (Greece)

^c NONE   (Greece)

Author keywords

Aldehyde dehydrogenase; Aldehyde oxidase; Allopurinol; Disulfiram; Isovanillin; Liver slices; Protocatechuic aldehyde; Vanillin; Xanthine oxidase

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE OXIDASE; ALLOPURINOL; DISULFIRAM; ISOVANILLIN; PROTOCATECHUALDEHYDE; VANILLIN; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME METABOLISM; ENZYME SPECIFICITY; ENZYME SUBSTRATE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INCUBATION TIME; KUPFFER CELL; LIVER MICROSOME METABOLISM; NONHUMAN; PRIORITY JOURNAL;

CAVIA PORCELLUS; SUS SCROFA;

EID: 11944257297     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083641     Document Type: Article

References (36)

1. Lerche-Langrand C, Toutain HJ: Precision-cut liver slices: characteristics and use for in vitro pharmacotoxicology. Toxicology 2000;153:221-253.
2. De Kanter R, Olinga P, De Jager MH, Merema MT, Meijer DKF, Groothius GMM: Organ slices as an in vitro test system for drug metabolism in human liver, lung and kidney. Toxicol In Vitro 1999;13:737-744.
3. Panoutsopoulos GI, Kouretas D, Gounaris EG, Beedham C: Metabolism of 2-phenylethylamine and phenylacetaldehyde by precision-cut guinea pig fresh liver slices. Eur J Drug Metab Pharcacokin 2004;29:111-118.
4. Price RJ, Renwick AB, Walters DG, Young PJ, Lake BG: Metabolism of nicotine and induction of CYP1A forms in precision-cut rat liver and lung slices. Toxicol In Vitro 2004;18:179-185.
5. Smith PF, Krack G, McKee RL, Johnson DG, Gandolfi AJ, Hruby VJ, Krumdieck CL, Brendel K: Maintenance of adult rat liver slices in dynamic organ culture. In Vitro Cell Dev Biol 1986;22:706-712.
6. Sipes IG, Fisher RL, Smith PF, Stine ER, Gandolfi AJ, Brendel K: A dynamic liver culture system: a tool for studying chemical biotransformation and toxicity. Arch Toxicol Suppl. 1987;11:20-33.
7. Dogterom P: Development of a simple incubation system for metabolism studies with precision-cut liver slices. Drug Metab Dispos 1993;21:699-704.
8. Fisher RL, Hasal SJ, Sanuik JT, Gandolfi AJ, Brendel K: Determination of optimal incubation media and suitable slice diameters in precision-cut liver slices: optimization of tissue slice culture, part 2. Toxicol Method 1995;5:115-130.
9. Lindahl R: Aldehyde dehydrogenases and their role in carcinogenesis. Crit Rev Biochem Mol Biol 1992;27:283-335.
10. Feron VJ, Til HP, de Vrijer F, Woutersen RA, Cassee FR, van Bladeren PJ: Aldehydes: occurrence, carcinogenic potential, mechanism of action and risk assessment. Mutat Res 1991;259:363-385.
11. Washio K, Makaya O, Sasaki H, Nishida K, Nakamura J, Shibasaki J: A new aspect of tolbutamide metabolism in the rabbit: the role of 1-butyl-3-(p- formylphenyl) sulphonylurea. J Pharm Pharmacol 1993; 45: 231-233.
12. Beedham C, Peet CF, Panoutsopoulos GI, Carter H, Smith JA: Role of aldehyde oxidase in biogenic amine metabolism. Prog Brain Res 1995;106:345-353.
13. Panoutsopoulos GI, Beedham C: Kinetics and specificity of guinea pig liver aldehyde oxidase and bovine milk xanthine oxidase towards substituted benzaldehydes. Acta Biochim Polon 2004;51:649-663.
14. Panoutsopoulos GI, Kouretas D, Beedham C: Contribution of aldehyde oxidase, xanthine oxidase and aldehyde dehydrogenase on the oxidation of aromatic aldehydes. Chem Res Toxicol 2004; 17: 1368-1376.
15. Yamanaka K, Iino H, Oikawa T: Purification and properties of dye-linked aldehyde dehydrogenase in Rhodopseudomonas acidophila M402. Agric Biol Chem 1991;55:989-996.
16. Klyosov AA: Kinetics and specificity of human liver aldehyde dehydrogenases toward aliphatic, aromatic, and fused polycyclic aldehydes. Biochemistry 1996;35:4457-4467.
17. Kuroda Y, Inouye T: Antimutagenesis by factors affecting DNA repair in bacteria. Mutat Res 1988;202:387-391.
18. Spillman PJ, Pollnitz AP, Liacopoulos D, Skouroumounis GK, Sefton MA: Accumulation of vanillin during barrel-aging of white, red, and model wines. J Agric Food Chem 1997;45:2584-2589.
19. Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK: Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 1997;15:1867-1876.
20. Akagi K, Hirose M, Hoshiya T, Mizoguchi Y, Ito N, Shrai T: Modulating effects of elagic acid, vanillin and quercetin in a rat medium term multi-organ carcinogenesis model. Cancer Lett 1995;94:113-121.
21. Tsuda H, Uehara N, Iwahori Y, Asamoto M, Iiogo M, Nagao M, Matsumoto K, Ito M, Hirono J: Chemoprotective effects of beta-carotene, alphatocopherol and five naturally occurring antioxidants on initiation of hepatocarcinogenesis by 2-amino-3-methylimidazo[4,5-f]quinoline in the rat. Jpn J Cancer Res 1994;85:1214-1219.
22. Liu J, Mori A: Antioxidant and prooxidant activities of p-hydroxybenzyl alcohol and vanillin: effects on free radicals, brain peroxidation and degradation of benzoate, deoxyribose, amino acids and DNA. Neuropharmacology 1993;32:659-669.
23. 2 in cultured Chinese hamster cells. Mutat Res 1992;268:231-237.
24. Durant S, Karran P: Vanillins - a novel family of DNA-PK inhibitors. Nucleic Acids Res 2003;31:5501-5512.
25. Wang Y, Hasuma T, Yano Y, Morishima Y, Matsui-Yuasa I, Otani S: Induction of apoptosis in CTLL-2 cells by protocatechualdehyde. Anticancer Res 2001;21:1095-1101.
26. Wang Y, Zhu Z, Hasuma T, Morishima Y, Matsui-Yuasa I, Otani S: Modulation of ornithine decarboxylase activity and mitogen-activated protein kinases in protocatechualdehyde-induced apoptosis of CTLL-2 cells. Anticancer Res 2002;22:3389-3394.
27. Beedham C, Bruce SE, Chritchley DJ, Rance DJ: 1-Substituted phthalazines as probes of the substrate-binding site of mammalian molybdenum hydroxylases. Biochem Pharmacol 1990;39:1213-1221.
28. Beedham C, Bruce SE, Critchley DJ, Al-Tayib Y, Rance DJ: Species variation in hepatic aldehyde oxidase activity. Eur J Drug Metab Pharmacokinet 1987;12:307-310.
29. Peterson GM, Boyle RR, Francis HW, Oliver NWJ, Paterson J, von Witt RJ, Taylor GR: Dosage prescribing and plasma oxipurinol levels in patients receiving allopurinol therapy. Eur J Pharmacol 1990;39:419-421.
30. Lipsky JJ, Shen ML, Naylor S: Overview-In vitro inhibition of aldehyde dehydrogenase by disulfiram and metabolites. Chem-Biol Interact 2001;130-132:81-91.
31. Deitrich RA, Erwin VG: Mechanism of the inhibition of aldehyde dehydrogenase in vivo by disulfiram and diethyldithiocarbamate. Mol Pharmacol 1971;7:301-307.
32. Rajagopalan KV, Handler P: Hepatic aldehyde oxidase. II. Differential inhibition of electron transfer to various electron acceptors. J Biol Chem 1964;239:2022-2026.
33. Lam JP, Mays DC, Lipsky JJ: Inhibition of recombinant human mitochondrial and cytosolic aldehyde dehydrogenases by two candidates for the active metabolites of disulfiram. Biochemistry 1997;36:13748-13754.
34. Vallari RC, Pietruszko R: Human aldehyde dehydrogenase: mechanism of inhibition of disulfiram. Science 1982;216:637-639.
35. Panoutsopoulos GI, Kouretas D, Gounaris EG, Beedham C: Enzymatic oxidation of 2-phenylethylamine to phenylacetic acid and 2-phenylethanol with special reference to the metabolism of its intermediate phenylacetaldehyde. Basic Clin Pharmacol Toxicol 2004;95: In press.
36. Panoutsopoulos GI, Beedham C: Enzymatic oxidation of phthalazine with freshly prepared precision-cut guinea pig liver slices. Acta Biochim Polon 2004;51:In press.